BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17015680)

  • 1. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections.
    French AR; Sjölin H; Kim S; Koka R; Yang L; Young DA; Cerboni C; Tomasello E; Ma A; Vivier E; Kärre K; Yokoyama WM
    J Immunol; 2006 Oct; 177(8):4981-90. PubMed ID: 17015680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
    Geurs TL; Zhao YM; Hill EB; French AR
    J Immunol; 2009 Nov; 183(9):5830-6. PubMed ID: 19828630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection.
    Dorner BG; Smith HR; French AR; Kim S; Poursine-Laurent J; Beckman DL; Pingel JT; Kroczek RA; Yokoyama WM
    J Immunol; 2004 Mar; 172(5):3119-31. PubMed ID: 14978118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
    Mason LH; Willette-Brown J; Taylor LS; McVicar DW
    J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous engagement of a self-specific activation receptor induces NK cell tolerance.
    Tripathy SK; Keyel PA; Yang L; Pingel JT; Cheng TP; Schneeberger A; Yokoyama WM
    J Exp Med; 2008 Aug; 205(8):1829-41. PubMed ID: 18606857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of NK cells encountering their viral ligand during development.
    Sun JC; Lanier LL
    J Exp Med; 2008 Aug; 205(8):1819-28. PubMed ID: 18606858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
    Rodriguez M; Sabastian P; Clark P; Brown MG
    J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
    Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
    J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of virulence caused by loss of a gene in murine cytomegalovirus.
    Bubić I; Wagner M; Krmpotić A; Saulig T; Kim S; Yokoyama WM; Jonjić S; Koszinowski UH
    J Virol; 2004 Jul; 78(14):7536-44. PubMed ID: 15220428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible.
    Bolanos FD; Tripathy SK
    J Immunol; 2011 Mar; 186(5):2765-71. PubMed ID: 21263069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection.
    Min-Oo G; Lanier LL
    J Exp Med; 2014 Dec; 211(13):2669-80. PubMed ID: 25422494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.
    Daniels KA; Devora G; Lai WC; O'Donnell CL; Bennett M; Welsh RM
    J Exp Med; 2001 Jul; 194(1):29-44. PubMed ID: 11435470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells.
    Parikh BA; Piersma SJ; Pak-Wittel MA; Yang L; Schreiber RD; Yokoyama WM
    PLoS Pathog; 2015 Dec; 11(12):e1005323. PubMed ID: 26720279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
    Tassi I; Presti R; Kim S; Yokoyama WM; Gilfillan S; Colonna M
    J Immunol; 2005 Jul; 175(2):749-54. PubMed ID: 16002670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
    Jensen IJ; Winborn CS; Fosdick MG; Shao P; Tremblay MM; Shan Q; Tripathy SK; Snyder CM; Xue HH; Griffith TS; Houtman JC; Badovinac VP
    PLoS Pathog; 2018 Oct; 14(10):e1007405. PubMed ID: 30379932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
    Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
    J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.
    Davis AH; Guseva NV; Ball BL; Heusel JW
    J Immunol; 2008 Jul; 181(1):265-75. PubMed ID: 18566392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection.
    Bekiaris V; Timoshenko O; Hou TZ; Toellner K; Shakib S; Gaspal F; McConnell FM; Parnell SM; Withers D; Buckley CD; Sweet C; Yokoyama WM; Anderson G; Lane PJ
    J Immunol; 2008 May; 180(10):6768-76. PubMed ID: 18453597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism.
    Mazumdar B; Bolanos FD; Tripathy SK
    Eur J Immunol; 2013 May; 43(5):1345-55. PubMed ID: 23440763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.
    Guseva NV; Fullenkamp CA; Naumann PW; Shey MR; Ballas ZK; Houtman JC; Forbes CA; Scalzo AA; Heusel JW
    Eur J Immunol; 2010 Sep; 40(9):2618-31. PubMed ID: 20662096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.